Download presentation
Presentation is loading. Please wait.
1
Supplemental Figure 1 A B panobinostat
2
Supplemental Figure 2 A Control 20 nM BC2059, 24 hr OCI-AML3 B
3
C D E Supplemental Figure 2 Control 20 50 100 nM BC2059, 48 hr
OCI-AML3 TO-PRO-3 iodide Annexin V-FITC D Control 50 nM BC2059, 48 hr HL-60 TO-PRO-3 iodide Annexin V-FITC E Control 20 50 nM BC2059, 48 hr Primary FLT3-ITD AML Propidium iodide
4
A B C D OCI-AML3 MV4-11 Primary FLT3-ITD AML Supplemental Figure 3
nM, BC2059, 24 h nM, BC2059, 24 h BIMEL BIMEL BIML BIML BIMS BIMS p27 p27 MCL1 β-Actin β-Actin D Primary FLT3-ITD AML nM, BC2059, 24 h β-Catenin BIMEL BIML BIMS p27 β-Actin
5
β Catenin Merge DAPI 100 nM BC2059 20 nM
Control DAPI TBL1 β-Catenin Merge TBL1/β-Catenin MV4-11 cells Supplemental Figure 4 A β-catenin DAPI Merge CD34+ Primary FLT3-ITD AML cells Control 50 nM BC2059 B Primary AML cells TBL1 β Catenin Merge DAPI Control 100 nM BC2059 20 nM D β-catenin DAPI Merge CD34+ FLT3 WT Primary AML cells Control 100 nM BC2059, 16 hours C
6
Supplemental Figure 5 A B C D
7
tryptophan 2,3-dioxygenase TDO2 204103_at 10.6149
Supplemental Table 1: Genes with greater than 3 fold induction in OCI-AML3 cells following treatment with 100 nM of BC-2059 for 8 hours. Probe Set ID Fold-Change Gene Title Gene Symbol 205943_at tryptophan 2,3-dioxygenase TDO2 204103_at chemokine (C-C motif) ligand 4 CCL4 216834_at regulator of G-protein signaling 1 RGS1 201739_at serum/glucocorticoid regulated kinase 1 SGK1 215078_at superoxide dismutase 2, mitochondrial SOD2 205114_s_at chemokine (C-C motif) ligand 3 CCL3 204472_at GTP binding protein overexpressed in skeletal muscle GEM 205476_at chemokine (C-C motif) ligand 20 CCL20 212724_at 4.6973 Rho family GTPase 3 RND3 201041_s_at 4.671 dual specificity phosphatase 1 DUSP1 220054_at interleukin 23, alpha subunit p19 IL23A 243296_at Nicotinamide phosphoribosyltransferase NAMPT 212099_at ras homolog gene family, member B RHOB 206025_s_at tumor necrosis factor, alpha-induced protein 6 TNFAIP6 _a_at prostaglandin-endoperoxide synthase 2 PTGS2 214038_at chemokine (C-C motif) ligand 8 CCL8 207433_at interleukin 10 IL10 230170_at oncostatin M OSM 216598_s_at chemokine (C-C motif) ligand 2 CCL2 201466_s_at jun proto-oncogene JUN 227697_at suppressor of cytokine signaling 3 SOCS3 219371_s_at Kruppel-like factor 2 (lung) KLF2 206115_at early growth response 3 EGR3 207850_at chemokine (C-X-C motif) ligand 3 CXCL3 204533_at chemokine (C-X-C motif) ligand 10 CXCL10 203665_at 3.2795 heme oxygenase (decycling) 1 HMOX1 209774_x_at chemokine (C-X-C motif) ligand 2 CXCL2 204748_at
8
solute carrier family 40 (iron-regulated transporter), member 1
Supplemental Table 2: Genes with greater than 2 fold depletion in OCI-AML3 cells following treatment with 100 nM of BC-2059 for 8 hours Probe Set ID Fold-Change Gene Title Gene Symbol 220184_at Nanog homeobox NANOG 204834_at fibrinogen-like 2 FGL2 223044_at solute carrier family 40 (iron-regulated transporter), member 1 SLC40A1 213436_at cannabinoid receptor 1 (brain) CNR1 207063_at non-protein coding RNA 185 NCRNA00185 204301_at kelch repeat and BTB (POZ) domain containing 11 KBTBD11 238900_at major histocompatibility complex, class II, DR beta 1 HLA-DRB1 240429_at zinc finger protein 546 ZNF546 206978_at chemokine (C-C motif) receptor 2 CCR2 228055_at napsin B aspartic peptidase pseudogene NAPSB 217047_s_at family with sequence similarity 13, member A FAM13A 233555_s_at sulfatase 2 SULF2 207794_at 227804_at TLC domain containing 1 TLCD1 219714_s_at calcium channel, voltage-dependent, alpha 2/delta subunit 3 CACNA2D3 217546_at metallothionein 1M MT1M 229545_at fermitin family member 1 FERMT1 211341_at POU class 4 homeobox 1 POU4F1 207761_s_at methyltransferase like 7A METTL7A 218858_at DEP domain containing 6 DEPDC6 207728_at activating transcription factor 7 interacting protein ATF7IP 213725_x_at xylosyltransferase I XYLT1
9
Associated Network Functions Score
Supplemental Table 3: Ingenuity Pathway Analysis of the 4 most perturbed networks in OCI-AML3 cells following treatment with 100 nM of BC-2059 for 8 hours. Network Associated Network Functions Score 1 Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking 31 2 Cell Morphology, Endocrine System Disorders, Gastrointestinal Disease 24 3 Neurological Disease, Organismal Injury and Abnormalities, Molecular Transport 21 4 Cellular Development, Cellular Growth and Proliferation, Hematological System Development and Function
10
* * C A B Supplemental Figure 6 OCI-AML3 BC2059 PS Fa CI (nM) (nM)
A HL-60 BC PS Fa CI (nM) (nM) MV4-11 BC2059 PS Fa CI (nM) (nM) B * *
11
A B Control 10 nM PS, 16 h 20 nM PS, 16 h 50 nM PS, 16h OCI-AML3
Supplemental Figure 7 OCI-AML3 cells A TBL1 DAPI Merge Control 10 nM PS, 16 h 20 nM PS, 16 h 50 nM PS, 16h β-Actin TBL1 OCI-AML3 nM, PS, 16 h B
12
AML #1 AML #2 BC2059 (nM) PS (nM) Fa CI 50 25 0.391 0.545 60 30 0.44
Supplemental Figure 8 AML #1 AML #2 BC2059 (nM) PS (nM) Fa CI 50 25 0.391 0.545 60 30 0.44 0.453 70 35 0.441 0.525 75 37.5 0.515 80 40 0.527 0.322 90 45 0.498 0.446 100 0.512 0.449 BC2059 (nM) PS (nM) Fa CI 50 25 0.47 0.993 60 30 0.625 0.624 70 35 0.611 0.773 75 37.5 0.668 0.644 80 40 0.653 0.735 90 45 0.694 0.761 100 0.512 0.449
Similar presentations
